일본과 해외의 조사회사나 출판사로부터 출판된 산업 조사 보고서 및 데이터 판매 · 연간 서비스 · 맞춤 정보 제공 ChosaReport-Korea 주식회사 SEMABIZ

의료 진단 분야의 인공 지능(AI) 시장조사 보고서

조사회사 : MarketsandMarkets (마켓츠앤마켓츠)   출판년월 : 2023년10월

AI in Medical Diagnostics Market – Global forecasts to 2028

의료 진단 분야의 인공 지능(AI) 시장 : 양식 (CT, X-Ray, MRI, 초음파), 용도 (IVD, 방사선과, CNS, CVS, 산부인과), 사용자 (병원, 연구실), 미충족 요구 사항, 주요 이해 관계자 및 구매 기준 – 2028년까지 세계 예측
Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (CT, X-Ray, MRI, Ultrasound), Application (IVD, Radiology, CNS, CVS, Ob/Gyn), User (Hospital, Labs), Unmet Need, Key Stakeholders & Buying Criteria – Global Forecast to 2028

페이지 수 327
도표 수 467
구성 영문조사보고서
가격

    주문/문의    조사회사/구입안내

Report Overview

The global AI in medical diagnostics market is projected to reach USD 3.7 Billion by 2028 from USD 1.3 Billion in 2023, at a CAGR of 23.2% during the forecast period. The adoption of AI in medical diagnostics is rising at a fast pace owing to factors such as growth in various  government initiatives to drive the uptake of AI-based technologies, AI solutions being more use by radiologists to decrease workload and the increasing number of cross-industry partnerships & collaborations.
However, the shortage of trained AI workforce, and unstable regulations are factors expected to restrain the market growth.

의료 진단 분야의 인공 지능(AI) 시장조사 보고서

“Services  segment is expected to grow at the highest rate from 2023 to 2028”
By component, AI in medical diagnostics market is divided into software,hardware, and services. The software segment accounted for the largest share of this market in 2022, while the services segment is estimated to grow at a higher CAGR from 2023 to 2028. Software solutions provide healthcare providers to gain a competitive edge despite the challenges of being short-staffed and facing mounting imaging scan volumes.

“In Vivo Diagnostics Segment is estimated to account for the largest share of the global AI in medical diagnostics market in 2023”
By application, AI in medical diagnostics market is divided into in vivo and in vitro diagnostics. In 2023, the in vivo diagnostics segment is projected to hold the largest share this market. Factors such as growing uptake of AI solutions by practitioners, as these solutions constantly help in decreasing human errors and enhance treatment efficacy.However,the in vitro diagnostics segment is projected to register highest growth during forecast period. The adoption of AI solutions is increasing for in vitro diagnostics applications as these solutions help reduce analysis and data interpretation time.

의료 진단 분야의 인공 지능(AI) 시장조사 보고서 - ecosystem

“The Hospitals segment is estimated to account for the largest share of the global AI in medical diagnostics market in 2023”
By end users, the AI in medical diagnostics market is divided into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. In 2023, the hospitals segment is projected to hold the largest market share of this market. Factors such as the increase in the adoption of minimally invasive procedures in hospitals to enhance the quality of patient care, and the advance in the application of advanced imaging modalities to improve workflow.


“North America  to dominate the AI in medical diagnostics market in 2023.”
By region, AI in medical diagnostics market has been segmented into five main regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America estimated to account for the largest market share of this market. However, the Asia Pacific market is projected to register the highest CAGR from 2023 to 2028. Factors such as increasing prevalence of cancer, and the implementation of favorable government initiatives.

의료 진단 분야의 인공 지능(AI) 시장조사 보고서 - region

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level (27%), Director-level (18%), and Others (55%)
• By Region: North America (40%), Europe (20%), Asia Pacific (30%), and RoW (10%)

The prominent players in this market are Microsoft (US), NVIDIA Corporation (US), Merative (US), Intel Corporation (US), Google (US), Siemens Healthineers (Germany), GE HealthCare (US), Digital Diagnostics Inc. (US), Advanced Micro Devices, Inc.  (US), InformAI (US), HeartFlow, Inc. (US), Enlitic, Inc.  (US), isometric (Belgium), Aidence (Netherlands), Butterfly Network, Inc. (US), Nano-X Imaging LTD. (Israel), Viz.ai, Inc (US), Quibim (Spain), Qure.ai (India), Therapixel (France), Aidoc (US), Koninklijke Philips N.V. (Netherlands), Lunit, Inc. (South Korea), EchoNous, Inc. (US), and Brainomix (UK).

Research Coverage
• The report studies the AI in medical diagnostics market based on component, application, end user, and region 
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total AI in medical diagnostics market
• The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the AI in medical diagnostics market and provides them information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
• Analysis of key drivers (influx of big data, growing cross-industry partnerships & collaborations, Increasing adoption of AI solutions to reduce work pressure on radiologists, rising government initiatives to drive AI-based technologies, availability of funding for AI-based startups), restraints (inadequate AI workforce and ambiguous regulatory guidelines for medical software), opportunities (untapped emerging markets, increasing focus on developing human-aware AI systems, challenges (reluctance to adopt AI-based technologies,budgetary constraints, unstructured healthcare data,data privacy concerns,limited interoperability)
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global AI in medical diagnostics Market. The report analyzes this market by component, application, end user.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the global AI in medical diagnostics Market
• Market Development: Comprehensive information on the lucrative emerging markets by component, application, end user.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global AI in medical diagnostics Market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global AI in medical diagnostics Market. 

Table of Contents

1            INTRODUCTION            45

1.1         STUDY OBJECTIVES      45

1.2         MARKET DEFINITION   45

1.2.1      INCLUSIONS AND EXCLUSIONS 45

1.3         MARKET SCOPE             46

1.3.1      MARKETS COVERED     46

1.3.2      YEARS CONSIDERED     46

1.3.3      CURRENCY CONSIDERED          47

1.4         STAKEHOLDERS            47

1.5         SUMMARY OF CHANGES            47

1.6         RECESSION IMPACT      48

2            RESEARCH METHODOLOGY     49

2.1         RESEARCH DATA           49

FIGURE 1           RESEARCH DESIGN       49

2.1.1      SECONDARY DATA       50

2.1.1.1   Key data from secondary sources     50

2.1.2      PRIMARY DATA 51

FIGURE 2           PRIMARY SOURCES       52

2.1.2.1   Key data from primary sources         53

2.1.2.2   Key industry insights          53

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION  54

2.2         MARKET SIZE ESTIMATION       54

FIGURE 4           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  54

FIGURE 5           MARKET SIZE ESTIMATION       55

TABLE 1             FACTOR ANALYSIS        56

FIGURE 6           AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)          57

FIGURE 7           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   57

FIGURE 8           TOP-DOWN APPROACH             58

2.3         MARKET DATA ESTIMATION AND TRIANGULATION     59

FIGURE 9           DATA TRIANGULATION METHODOLOGY         59

2.4         ASSUMPTIONS 60

2.5         LIMITATIONS   60

2.5.1      SCOPE-RELATED LIMITATIONS             60

2.5.2      METHODOLOGY-RELATED LIMITATIONS         60

2.6         RISK ASSESSMENT         61

TABLE 2             RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET              61

2.7         AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS              61

3            EXECUTIVE SUMMARY 62

FIGURE 10         AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2023 VS. 2028 (USD MILLION)     62

FIGURE 11         AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)     63

FIGURE 12         AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)             63

FIGURE 13         GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET            64

4            PREMIUM INSIGHTS      65

4.1         AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW       65

FIGURE 14         RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF  BIG DATA TO DRIVE MARKET            65

4.2         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET,  BY APPLICATION AND COUNTRY (2022)    66

FIGURE 15         IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA  IN 2022        66

4.3         AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           66

FIGURE 16         ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE    66

4.4         AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX             67

FIGURE 17         ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD       67

4.5         AI IN MEDICAL DIAGNOSTICS MARKET:  DEVELOPED MARKETS VS. EMERGING ECONOMIES            67

FIGURE 18         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD         67

5            MARKET OVERVIEW     68

5.1         INTRODUCTION            68

FIGURE 19        AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    68

5.1.1      DRIVERS            69

5.1.1.1   Influx of big data  69

5.1.1.2   Growing cross-industry partnerships & collaborations 69

5.1.1.3   Increasing demand for AI-based solutions to reduce work pressure on radiologists              70

5.1.1.4   Rising government initiatives to support AI-based technologies 70

5.1.1.5   Availability of funding for AI-based startups  71

5.1.2      RESTRAINTS     72

5.1.2.1   Inadequate AI workforce and ambiguous regulatory guidelines for medical software 72

5.1.3      OPPORTUNITIES           72

5.1.3.1   Untapped emerging markets            72

5.1.3.2   Increasing focus on developing human-aware AI systems           73

5.1.4      CHALLENGES   73

5.1.4.1   Reluctance to adopt AI-based technologies    73

5.1.4.2   Budgetary constraints        74

5.1.4.3   Unstructured healthcare data           74

5.1.4.4   Data privacy concerns        74

5.1.4.5   Limited interoperability     75

5.2         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS     75

FIGURE 20         REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS            75

5.3         VALUE CHAIN ANALYSIS            75

FIGURE 21         AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN 76

5.3.1      UPSTREAM       76

5.3.2      MID-STREAM    77

5.3.3      DOWNSTREAM 77

5.4         ECOSYSTEM MAPPING 77

FIGURE 22         AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM    77

5.4.1      ROLE IN ECOSYSTEM    78

5.5         CASE STUDIES  79

5.5.1      MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM         79

5.5.2      RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES 79

5.5.3      NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING          79

5.5.4      ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND           80

5.5.5      WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS          80

5.6         TECHNOLOGY ANALYSIS           81

5.6.1      MACHINE LEARNING    81

5.6.2      NATURAL LANGUAGE PROCESSING      81

5.6.3      COMPUTER VISION       81

TABLE 3             TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS              81

5.7         PORTER’S FIVE FORCES ANALYSIS         82

TABLE 4             AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS         82

5.7.1      THREAT OF NEW ENTRANTS    83

5.7.2      THREAT OF SUBSTITUTES         83

5.7.3      BARGAINING POWER OF SUPPLIERS     83

5.7.4      BARGAINING POWER OF BUYERS           83

5.7.5      INTENSITY OF COMPETITIVE RIVALRY 84

5.8         INDUSTRY TRENDS       84

5.8.1      ARTIFICIAL INTELLIGENCE IN HEALTHCARE    84

5.8.1.1   Key to AI in Healthcare: Data          84

5.8.1.2   AR and MR in Healthcare Settings   84

5.8.1.3   Healthcare Privacy and Security in 2022        84

5.8.1.4   Growing demand for AI among companies offering at-home IVD testing services              85

5.9         TRADE ANALYSIS          85

FIGURE 23         EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND) 85

FIGURE 24         IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND) 86

5.10       TARIFF AND REGULATORY ANALYSIS   86

5.10.1    TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE 86

TABLE 5             TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022         86

TABLE 6             TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022  86

TABLE 7             TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020         87

5.10.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          87

TABLE 8             NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         87

TABLE 9             EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         88

TABLE 10           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         89

TABLE 11           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS       89

5.10.3    NORTH AMERICA          90

FIGURE 25         ALGORITHMS CLEARED BY US FDA, 2008 TO 2023           91

5.10.3.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA)    91

5.10.3.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH)          91

5.10.3.3 Consumer Privacy Protection Act of 2017      91

5.10.3.4 National Cybersecurity Protection Advancement Act of 2015    91

5.10.3.5 Future of Life Institute’s Asilomar AI Principles          92

5.10.4    EUROPE             92

5.10.4.1 European Medical Devices Regulation (EU) 2017/745 and In-vitro Diagnostic Medical Devices Regulation (EU) 2017/746, in combination with General Data Protection Regulation 2016/679         92

5.10.4.2 AI Act (Artificial Intelligence Act)   92

5.10.5    ASIA PACIFIC    93

5.10.5.1 Cybersecurity Law of the People’s Republic of China   93

5.10.6    REST OF THE WORLD   93

5.10.6.1 Protection of Personal Information Act          93

5.11       PRICING ANALYSIS        94

FIGURE 26         AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR)        94

TABLE 12           AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE     94

5.11.1    AVERAGE SELLING PRICE TREND          95

5.12       PATENT ANALYSIS        95

5.12.1    PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS            95

FIGURE 27         PATENT PUBLICATION TRENDS (2019-2023)      95

5.12.2    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS        95

FIGURE 28         TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023) 96

TABLE 13           LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET 96

5.13       KEY CONFERENCES AND EVENTS (2023–2024)   98

TABLE 14           AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS    98

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    99

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         99

TABLE 15           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS       99

FIGURE 29         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS       100

TABLE 16           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS       100

5.14.2    BUYING CRITERIA         100

FIGURE 30         KEY BUYING CRITERIA FOR END USERS              100

TABLE 17           KEY BUYING CRITERIA FOR END USERS              101

5.15       UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET             101

TABLE 18           AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS              101

5.16       END-USER EXPECTATIONS       102

TABLE 19           AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS             102

5.17       REIMBURSEMENT SCENARIO    103

TABLE 20           SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE        104

TABLE 21           DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT         104

5.17.1    REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY   105

6            ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY COMPONENT   106

6.1         INTRODUCTION            107

TABLE 22           AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)          107

TABLE 23           AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)          107

6.2         SOFTWARE       107

6.2.1      USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS  107

TABLE 24           AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 108

TABLE 25           AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 109

6.3         SERVICES          109

6.3.1      RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH        109

TABLE 26           AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 110

TABLE 27           AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 110

6.4         HARDWARE      111

6.4.1      FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH          111

TABLE 28           AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)          111

TABLE 29           AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)          111

TABLE 30           AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 112

TABLE 31           AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 112

6.4.2      PROCESSORS    113

TABLE 32           PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)              113

TABLE 33           PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)              113

TABLE 34           PROCESSORS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)          114

TABLE 35           PROCESSORS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)          114

6.4.2.1   MPU     115

6.4.2.1.1 MPUs to hold largest share of processors market         115

TABLE 36           MPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)              115

TABLE 37           MPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)              116

6.4.2.2   GPU      116

6.4.2.2.1 GPUs play crucial role in enhancing accuracy and efficacy of imaging      116

TABLE 38           GPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 117

TABLE 39           GPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 117

6.4.2.3   FPGA    118

6.4.2.3.1 Wide usage potential to drive demand            118

TABLE 40           FPGA MARKET, BY COUNTRY, 2017–2021 (USD MILLION)              118

TABLE 41           FPGA MARKET, BY COUNTRY, 2022–2028 (USD MILLION)              119

6.4.2.4   ASIC      119

6.4.2.4.1 Rapid operations to support end-user demand             119

TABLE 42           ASIC MARKET, BY COUNTRY, 2017–2021 (USD MILLION)              120

TABLE 43           ASIC MARKET, BY COUNTRY, 2022–2028 (USD MILLION)              120

6.4.3      MEMORY           121

6.4.3.1   Development of high-bandwidth memory for AI applications to drive market              121

TABLE 44           AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 121

TABLE 45           AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 122

6.4.4      NETWORKS       122

TABLE 46           AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          122

TABLE 47           AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          123

TABLE 48           AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 123

TABLE 49           AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 124

6.4.4.1   Adapters 124

6.4.4.1.1 Adapters to hold largest share of networks market        124

TABLE 50           ADAPTERS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)              125

TABLE 51           ADAPTERS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)              125

6.4.4.2   Switches 126

TABLE 52           SWITCHES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)              126

TABLE 53           SWITCHES MARKET, BY COUNTRY, 2022–2028 (USD MILLION)              127

6.4.4.3   Interconnects       127

6.4.4.3.1 Need for efficient data transmission to drive market    127

TABLE 54           INTERCONNECTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)          128

TABLE 55           INTERCONNECTS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)          128

7            ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY APPLICATION  129

7.1         INTRODUCTION            130

TABLE 56           AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)          130

TABLE 57           AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)          130

7.2         IN VIVO DIAGNOSTICS 131

7.2.1      IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY             131

TABLE 58           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY,  2017–2021 (USD MILLION)        131

TABLE 59           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY,  2022–2028 (USD MILLION)        131

TABLE 60           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES,  BY COUNTRY, 2017–2021 (USD MILLION)  132

TABLE 61           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES,  BY COUNTRY, 2022–2028 (USD MILLION)  132

7.2.1.1   Radiology            133

7.2.1.1.1 AI-based diagnostic tools to reduce work pressure on radiologists            133

TABLE 62           AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)          133

TABLE 63           AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)          134

7.2.1.2   Cardiology           134

7.2.1.2.1 Rising complexities associated with CVD to drive market           134

TABLE 64           AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,  2017–2021 (USD MILLION) 135

TABLE 65           AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,  2022–2028 (USD MILLION) 135

7.2.1.3   Neurology           136

7.2.1.3.1 Increasing prevalence of critical brain disorders to drive market 136

TABLE 66           AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY,  2017–2021 (USD MILLION) 137

TABLE 67           AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY,  2022–2028 (USD MILLION) 137

7.2.1.4   Obstetrics/Gynecology      138

7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market   138

TABLE 68           AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)  138

TABLE 69           AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)  139

7.2.1.5   Ophthalmology   139

7.2.1.5.1 Rising need for early detection & prevention of eye diseases to drive market              139

TABLE 70           AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY,  2017–2021 (USD MILLION) 140

TABLE 71           AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY,  2022–2028 (USD MILLION) 140

7.2.1.6   Other specialties  141

TABLE 72           AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY,  2017–2021 (USD MILLION)            141

TABLE 73           AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY,  2022–2028 (USD MILLION)            142

7.2.2      IN VIVO DIAGNOSTICS MARKET, BY MODALITY             142

TABLE 74           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY,  2017–2021 (USD MILLION)        142

TABLE 75           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY,  2022–2028 (USD MILLION)        143

TABLE 76           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES,  BY COUNTRY, 2017–2021 (USD MILLION)  143

TABLE 77           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES,  BY COUNTRY, 2022–2028 (USD MILLION)  144

7.2.2.1   CT         144

7.2.2.1.1 Rising availability of cardiac CT devices with AI solutions to drive market              144

TABLE 78           AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017–2021 (USD MILLION)          145

TABLE 79           AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022–2028 (USD MILLION)          145

7.2.2.2   X-ray     146

7.2.2.2.1 Innovative AI solutions for x-ray imaging by key players to drive market  146

TABLE 80           AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY,  2017–2021 (USD MILLION) 146

TABLE 81           AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY,  2022–2028 (USD MILLION) 147

7.2.2.3   MRI       147

7.2.2.3.1 Rising technological advancements to drive adoption of  AI in MRI        147

TABLE 82          AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY,  2017–2021 (USD MILLION)          148

TABLE 83          AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY,  2022–2028 (USD MILLION)          148

7.2.2.4   Ultrasound          149

7.2.2.4.1 Increasing prevalence of ovarian cancer to boost demand           149

TABLE 84           AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION) 149

TABLE 85           AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY,  2022–2028 (USD MILLION) 150

7.2.2.5   Other modalities  150

TABLE 86           FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING              150

TABLE 87           AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY,  2017–2021 (USD MILLION)            151

TABLE 88           AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY,  2022–2028 (USD MILLION)            151

7.3         IN VITRO DIAGNOSTICS            152

7.3.1      INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH           152

TABLE 89           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,  2017–2021 (USD MILLION)          152

TABLE 90           AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,  2022–2028 (USD MILLION)          153

8            ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY END USER         154

8.1         INTRODUCTION            155

TABLE 91           AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)     155

TABLE 92           AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)     155

8.2         HOSPITALS       156

8.2.1      INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET       156

TABLE 93           AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,  2017–2021 (USD MILLION) 156

TABLE 94           AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,  2022–2028 (USD MILLION) 157

8.3         DIAGNOSTIC IMAGING CENTERS          157

8.3.1      GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET            157

TABLE 95           AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY COUNTRY, 2017–2021 (USD MILLION) 158

TABLE 96           AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY COUNTRY, 2022–2028 (USD MILLION) 158

8.4         DIAGNOSTIC LABORATORIES   159

8.4.1      RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET 159

TABLE 97           AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2017–2021 (USD MILLION)       159

TABLE 98           AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2022–2028 (USD MILLION)       160

8.5         OTHER END USERS        160

TABLE 99           AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,  2017–2021 (USD MILLION)          161

TABLE 100         AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2028 (USD MILLION)          161

9            ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY REGION             162

9.1         INTRODUCTION            163

TABLE 101         AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017–2021 (USD MILLION) 163

TABLE 102         AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022–2028 (USD MILLION) 163

9.2         NORTH AMERICA          164

9.2.1      NORTH AMERICA: RECESSION IMPACT 164

FIGURE 31         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT        165

TABLE 103         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 165

TABLE 104         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 166

TABLE 105         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        166

TABLE 106         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        166

TABLE 107         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)       167

TABLE 108         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)       167

TABLE 109         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)       168

TABLE 110         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)       168

TABLE 111         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         168

TABLE 112         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         169

TABLE 113         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION) 169

TABLE 114         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION) 169

TABLE 115         NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 170

TABLE 116         NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 170

TABLE 117         NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 170

TABLE 118         NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 171

TABLE 119         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION) 171

TABLE 120         NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION) 171

9.2.2      US         172

9.2.2.1   Increasing volume of imaging procedures to drive market          172

TABLE 121         US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)          173

TABLE 122         US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)          173

TABLE 123         US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)           173

TABLE 124         US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)           174

TABLE 125         US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)           174

TABLE 126         US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)           175

TABLE 127         US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)          175

TABLE 128         US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)          175

TABLE 129         US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          176

TABLE 130         US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          176

TABLE 131         US: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)              176

TABLE 132         US: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)              177

TABLE 133         US: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)              177

TABLE 134         US: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)              177

TABLE 135         US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)          178

TABLE 136         US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)          178

9.2.3      CANADA            178

9.2.3.1   Research grants and improved academics in radiology to drive market     178

TABLE 137         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        179

TABLE 138         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        179

TABLE 139         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)        179

TABLE 140         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)        180

TABLE 141         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)        180

TABLE 142         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)        180

TABLE 143         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         181

TABLE 144         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         181

TABLE 145         CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)    181

TABLE 146         CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)    182

TABLE 147         CANADA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          182

TABLE 148         CANADA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          182

TABLE 149         CANADA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          183

TABLE 150         CANADA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          183

TABLE 151         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          183

TABLE 152         CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          184

9.3         EUROPE             184

9.3.1      EUROPE: RECESSION IMPACT   184

TABLE 153         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 185

TABLE 154         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 185

TABLE 155         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        186

TABLE 156         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        186

TABLE 157         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)        186

TABLE 158         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)        187

TABLE 159         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)        187

TABLE 160         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)        187

TABLE 161         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         188

TABLE 162         EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         188

TABLE 163         EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)    188

TABLE 164         EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)    189

TABLE 165         EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          189

TABLE 166         EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          189

TABLE 167         EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          190

TABLE 168         EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          190

TABLE 169        EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          190

TABLE 170        EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          191

9.3.2      GERMANY         191

9.3.2.1   Rising government support to drive adoption of AI in medical diagnostics              191

TABLE 171         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        192

TABLE 172         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        192

TABLE 173         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)            192

TABLE 174         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)            193

TABLE 175         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)            193

TABLE 176         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)            193

TABLE 177         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         194

TABLE 178         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         194

TABLE 179         GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION) 194

TABLE 180         GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION) 195

TABLE 181         GERMANY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          195

TABLE 182         GERMANY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          195

TABLE 183         GERMANY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          196

TABLE 184         GERMANY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          196

TABLE 185         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          196

TABLE 186         GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          197

9.3.3      FRANCE             197

9.3.3.1   Availability of funding for companies to enhance AI research in medical imaging              197

TABLE 187         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        198

TABLE 188         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        198

TABLE 189         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)        198

TABLE 190         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)        199

TABLE 191         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)        199

TABLE 192         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)        199

TABLE 193         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         200

TABLE 194         FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         200

TABLE 195         FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)    200

TABLE 196         FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)    201

TABLE 197         FRANCE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          201

TABLE 198         FRANCE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          201

TABLE 199         FRANCE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          202

TABLE 200         FRANCE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          202

TABLE 201        FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          202

TABLE 202        FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          203

9.3.4      UK         203

9.3.4.1   Increasing radiography procedures to drive market      203

TABLE 203         UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)          204

TABLE 204         UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)          204

TABLE 205         UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)           204

TABLE 206         UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)           205

TABLE 207         UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)           205

TABLE 208         UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)           205

TABLE 209         UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)          206

TABLE 210         UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)          206

TABLE 211         UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          206

TABLE 212         UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          207

TABLE 213         UK: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)              207

TABLE 214         UK: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)              207

TABLE 215         UK: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)              208

TABLE 216         UK: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)              208

TABLE 217         UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)          208

TABLE 218         UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)          209

9.3.5      ITALY   209

9.3.5.1   Increasing volume of EHRs and EMRs due to rising geriatric population to drive demand for AI solutions     209

TABLE 219         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        209

TABLE 220         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        210

TABLE 221         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)           210

TABLE 222         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)           210

TABLE 223         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)           211

TABLE 224         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)           211

TABLE 225         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         211

TABLE 226         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         212

TABLE 227         ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          212

TABLE 228         ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          212

TABLE 229         ITALY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          213

TABLE 230         ITALY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          213

TABLE 231         ITALY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          213

TABLE 232         ITALY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          214

TABLE 233         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)          214

TABLE 234         ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)          214

9.3.6      SPAIN   215

9.3.6.1   Growing awareness of AI in Spain to favor market growth          215

TABLE 235         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        215

TABLE 236         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        215

TABLE 237         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)           216

TABLE 238         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)           216

TABLE 239         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)           217

TABLE 240         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)           217

TABLE 241         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         217

TABLE 242         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         218

TABLE 243         SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          218

TABLE 244         SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          218

TABLE 245         SPAIN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          219

TABLE 246         SPAIN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          219

TABLE 247         SPAIN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          219

TABLE 248         SPAIN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          220

TABLE 249         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)          220

TABLE 250         SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)          220

9.3.7      REST OF EUROPE           221

TABLE 251         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        221

TABLE 252         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        221

TABLE 253         REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)       222

TABLE 254         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)       222

TABLE 255         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)       223

TABLE 256         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)       223

TABLE 257         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         223

TABLE 258         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         224

TABLE 259         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION) 224

TABLE 260         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION) 224

TABLE 261         REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225

TABLE 262         REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 225

TABLE 263         REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225

TABLE 264         REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 226

TABLE 265         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION) 226

TABLE 266         REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION) 226

9.4         ASIA PACIFIC    227

9.4.1      ASIA PACIFIC: RECESSION IMPACT        227

FIGURE 32         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT        228

TABLE 267         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION) 228

TABLE 268         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION) 229

TABLE 269         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        229

TABLE 270         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        229

TABLE 271         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)            230

TABLE 272         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)            230

TABLE 273         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)            231

TABLE 274         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)            231

TABLE 275         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         231

TABLE 276         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         232

TABLE 277         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION) 232

TABLE 278         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION) 232

TABLE 279         ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          233

TABLE 280         ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          233

TABLE 281         ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          233

TABLE 282         ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          234

TABLE 283         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          234

TABLE 284         ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          234

9.4.2      CHINA  235

9.4.2.1   Rising use of AI in clinical decision-making to drive market       235

TABLE 285         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        235

TABLE 286         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        236

TABLE 287         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)        236

TABLE 288         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)        236

TABLE 289         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)        237

TABLE 290         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)        237

TABLE 291         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         237

TABLE 292         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         238

TABLE 293         CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          238

TABLE 294         CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          238

TABLE 295         CHINA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          239

TABLE 296         CHINA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          239

TABLE 297         CHINA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          239

TABLE 298         CHINA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          240

TABLE 299         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          240

TABLE 300         CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          240

9.4.3      JAPAN  241

9.4.3.1   Strong healthcare infrastructure to drive uptake of advanced AI solutions 241

TABLE 301         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        241

TABLE 302         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        241

TABLE 303         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)        242

TABLE 304         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)        242

TABLE 305         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)        242

TABLE 306         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)        243

TABLE 307         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         243

TABLE 308         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         243

TABLE 309         JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          244

TABLE 310         JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          244

TABLE 311         JAPAN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          244

TABLE 312         JAPAN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          245

TABLE 313         JAPAN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          245

TABLE 314         JAPAN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          245

TABLE 315         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          246

TABLE 316         JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          246

9.4.4      INDIA   246

9.4.4.1   Favorable government initiatives for R&D investments to drive market    246

TABLE 317         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        247

TABLE 318         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        247

TABLE 319         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)        248

TABLE 320         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)        248

TABLE 321         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)        249

TABLE 322         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)        249

TABLE 323         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         249

TABLE 324         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         250

TABLE 325         INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)          250

TABLE 326         INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)          250

TABLE 327         INDIA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          251

TABLE 328         INDIA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          251

TABLE 329         INDIA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)          251

TABLE 330         INDIA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)          252

TABLE 331         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)          252

TABLE 332         INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)          252

9.4.5      REST OF ASIA PACIFIC  253

TABLE 333         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)   253

TABLE 334         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)   253

TABLE 335         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)              254

TABLE 336         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)              254

TABLE 337         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)              255

TABLE 338         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)              255

TABLE 339         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)   255

TABLE 340         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)   256

TABLE 341         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)         256

TABLE 342         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)         256

TABLE 343         REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)     257

TABLE 344         REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)     257

TABLE 345         REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)     257

TABLE 346         REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)     258

TABLE 347         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)         258

TABLE 348         REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)         258

9.5         LATIN AMERICA             259

9.5.1      RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS   259

9.5.2      LATIN AMERICA: RECESSION IMPACT   259

TABLE 349         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)        259

TABLE 350         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)        260

TABLE 351         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)       260

TABLE 352         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)       260

TABLE 353         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)       261

TABLE 354         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)       261

TABLE 355         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)         261

TABLE 356         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)         262

TABLE 357         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021(USD MILLION)  262

TABLE 358         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION) 262

TABLE 359         LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 263

TABLE 360         LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 263

TABLE 361         LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 263

TABLE 362         LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 264

TABLE 363         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION) 264

TABLE 364         LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION) 264

9.6         MIDDLE EAST & AFRICA             265

9.6.1      GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI              265

9.6.2      MIDDLE EAST & AFRICA: RECESSION IMPACT   265

TABLE 365         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)             265

TABLE 366         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)             266

TABLE 367         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)              266

TABLE 368         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)              266

TABLE 369         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)              267

TABLE 370         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)              267

TABLE 371         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION) 267

TABLE 372         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION) 268

TABLE 373         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)         268

TABLE 374         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)         268

TABLE 375         MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)          269

TABLE 376         MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)          269

TABLE 377         MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)     269

TABLE 378         MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)     270

TABLE 379         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)      270

TABLE 380         MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)      270

10          COMPETITIVE LANDSCAPE       271

10.1       OVERVIEW        271

10.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          271

TABLE 381         OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS       271

10.3       REVENUE ANALYSIS      272

FIGURE 33         REVENUE ANALYSIS OF KEY PLAYERS, 2017–2022            273

10.4       MARKET SHARE ANALYSIS         273

FIGURE 34         AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022)   273

TABLE 382         AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION 274

FIGURE 35         AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022)        274

10.5       COMPANY EVALUATION MATRIX          275

10.5.1    STARS  275

10.5.2    EMERGING LEADERS    275

10.5.3    PERVASIVE PLAYERS     275

10.5.4    PARTICIPANTS 276

FIGURE 36         AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022      276

10.5.5    COMPANY FOOTPRINT ANALYSIS         276

TABLE 383         OVERALL COMPANY FOOTPRINT (TEN PLAYERS)         276

TABLE 384         APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS)     277

TABLE 385         REGIONAL FOOTPRINT (TEN PLAYERS)             277

10.6       START-UP/SME EVALUATION MATRIX 278

10.6.1    PROGRESSIVE COMPANIES       278

10.6.2    DYNAMIC COMPANIES 278

10.6.3    RESPONSIVE COMPANIES          278

10.6.4    STARTING BLOCKS       278

FIGURE 37         AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022)    279

10.6.5    COMPETITIVE BENCHMARKING            279

TABLE 386         AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES  279

TABLE 387         AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) 280

10.7       COMPETITIVE SCENARIO          281

10.7.1    PRODUCT LAUNCHES & ENHANCEMENTS         281

TABLE 388         AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020–SEPTEMBER 2023    281

10.7.2    DEALS  282

TABLE 389         KEY DEALS, JANUARY 2020–SEPTEMBER 2023     282

10.7.3    OTHER DEVELOPMENTS           283

TABLE 390         AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS  (JANUARY 2020–SEPTEMBER 2023)   283

11          COMPANY PROFILES    284

11.1       KEY PLAYERS   284

(Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)*

11.1.1    MICROSOFT      284

TABLE 391         MICROSOFT: COMPANY OVERVIEW      284

FIGURE 38         MICROSOFT: COMPANY SNAPSHOT (2022)        285

11.1.2    NVIDIA CORPORATION 289

TABLE 392         NVIDIA CORPORATION: COMPANY OVERVIEW 289

FIGURE 39         NVIDIA CORPORATION: COMPANY SNAPSHOT (2022)  290

11.1.3    MERATIVE        294

TABLE 393         MERATIVE: COMPANY OVERVIEW         294

FIGURE 40         IBM: COMPANY SNAPSHOT (2021)         295

11.1.4    GOOGLE (ALPHABET, INC.)       298

TABLE 394         GOOGLE: COMPANY OVERVIEW            298

FIGURE 41         GOOGLE: COMPANY SNAPSHOT (2022) 299

11.1.5    INTEL CORPORATION  302

TABLE 395         INTEL CORPORATION: COMPANY OVERVIEW  302

FIGURE 42         INTEL CORPORATION: COMPANY SNAPSHOT (2022)     303

11.1.6    SIEMENS HEALTHINEERS          307

TABLE 396         SIEMENS HEALTHINEERS: COMPANY OVERVIEW           307

FIGURE 43         SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)              308

11.1.7    GE HEALTHCARE          311

TABLE 397         GE HEALTHCARE: COMPANY OVERVIEW           311

FIGURE 44         GE HEALTHCARE: COMPANY SNAPSHOT (2022)             312

11.1.8    ADVANCED MICRO DEVICES, INC.         316

TABLE 398         ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW              316

FIGURE 45         XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022)          316

11.1.9    KONINKLIJKE PHILIPS N.V.        319

TABLE 399         KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW         319

FIGURE 46         KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)              320

11.1.10  DIGITAL DIAGNOSTICS, INC.    323

TABLE 400         DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW     323

11.1.11  INFORMAI         326

TABLE 401         INFORMAI: COMPANY OVERVIEW          326

11.2       OTHER PLAYERS           328

11.2.1    HEARTFLOW, INC.         328

11.2.2    ENLITIC, INC.    328

11.2.3    AIDENCE           329

11.2.4    BUTTERFLY NETWORK, INC.     329

11.2.5    NANO X IMAGING LTD. 330

11.2.6    VIZ.AI, INC.        330

11.2.7    QUIBIM              331

11.2.8    QURE.AI             331

11.2.9    THERAPIXEL    332

11.2.10  AIDOC  332

11.2.11  LUNIT, INC.       333

11.2.12  ECHONOUS, INC.           333

11.2.13  ICOMETRIX       334

11.2.14  BRAINOMIX       334

*Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

12          APPENDIX         335

12.1       DISCUSSION GUIDE      335

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             338

12.3       CUSTOMIZATION OPTIONS      340

12.4       RELATED REPORTS       340

12.5       AUTHOR DETAILS         341


    주문/문의폼

    • 리포트 제목은 자동으로 입력됩니다.

    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com